These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7970835)

  • 21. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
    Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
    Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
    Brogan SE; Winter NB; Okifuji A
    Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spinal opiate analgesia].
    Zenz M
    Arzneimittelforschung; 1984; 34(9A):1089-92. PubMed ID: 6548637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal narcotics for relief of pain from head and neck cancer.
    Andersen PE; Cohen JI; Everts EC; Bedder MD; Burchiel KJ
    Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1277-80. PubMed ID: 1747233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF.
    Wong CS; Chang YC; Yeh CC; Huang GS; Cherng CH
    Can J Anaesth; 2002; 49(6):561-5. PubMed ID: 12067866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose intrathecal naloxone to enhance intrathecal morphine analgesia: a case report.
    Hamann S; Sloan PA; Witt W
    J Opioid Manag; 2008; 4(4):251-4. PubMed ID: 18837205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
    Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
    Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal betamethasone for cancer pain in the lower half of the body: a study of its analgesic efficacy and safety.
    Taguchi H; Oishi K; Sakamoto S; Shingu K
    Br J Anaesth; 2007 Mar; 98(3):385-9. PubMed ID: 17227818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of intraventricular morphine analgesia in intractable neoplasm pain. Apropos of 8 cases with self-administration in 4].
    Roquefeuil B; Benezech J; Batier C; Blanchet P; Gros C; Mathieu-Daude JC
    Neurochirurgie; 1983; 29(2):135-41. PubMed ID: 6888632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.
    Hamann S; Sloan P
    J Opioid Manag; 2007; 3(3):137-44. PubMed ID: 18027539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Edmonton injector: a simple device for patient-controlled subcutaneous analgesia.
    Bruera E; MacMillan K; Hanson J; MacDonald NR
    Pain; 1991 Feb; 44(2):167-169. PubMed ID: 2052383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of the pain syndrome in cancer patients by peridural administration of low doses of opiates].
    Isakova ME; Larionova VB; Sidorkin VA; Tsirikhov SM
    Vopr Onkol; 1987; 33(9):94-7. PubMed ID: 3660762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in G proteins genes expression in rat lumbar spinal cord support the inhibitory effect of chronic pain on the development of tolerance to morphine analgesia.
    Javan M; Ahmadiani A; Motamadi F; Kazemi B
    Neurosci Res; 2005 Nov; 53(3):250-6. PubMed ID: 16055216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pain treatment by sub or epidural opiate administration].
    Grabow L
    Anasth Intensivther Notfallmed; 1982 Jun; 17(3):161-4. PubMed ID: 6896965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
    Dudgeon DJ; Bruera E; Gagnon B; Watanabe SM; Allan SJ; Warr DG; MacDonald SM; Savage C; Tu D; Pater JL
    J Pain Symptom Manage; 2007 Apr; 33(4):365-71. PubMed ID: 17397698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of chronic intractable angina - spinal opioids offer an alternative therapy.
    Cherry DA; Gourlay GK; Eldredge KA
    Pain; 2003 Mar; 102(1-2):163-6. PubMed ID: 12620607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance during long-term administration of intrathecal morphine.
    Ali NM; Hoffman JS
    Conn Med; 1989 May; 53(5):266-8. PubMed ID: 2736913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesia with oral narcotics and added ibuprofen in cancer patients.
    Weingart WA; Sorkness CA; Earhart RH
    Clin Pharm; 1985; 4(1):53-8. PubMed ID: 3971683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal and intraventricular morphine for pain in cancer patients: initial study.
    Leavens ME; Hill CS; Cech DA; Weyland JB; Weston JS
    J Neurosurg; 1982 Feb; 56(2):241-5. PubMed ID: 6172573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
    Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
    Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.